Suppr超能文献

人乳头瘤病毒相关口腔鳞状细胞癌的多参数免疫分析

Multiparametric immune profiling in HPV- oral squamous cell cancer.

作者信息

Feng Zipei, Bethmann Daniel, Kappler Matthias, Ballesteros-Merino Carmen, Eckert Alexander, Bell R Bryan, Cheng Allen, Bui Tuan, Leidner Rom, Urba Walter J, Johnson Kent, Hoyt Clifford, Bifulco Carlo B, Bukur Juergen, Wickenhauser Claudia, Seliger Barbara, Fox Bernard A

机构信息

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Portland, Oregon, USA.

Department of Cancer Biology, Oregon Health & Science University, Portland, Oregon, USA.

出版信息

JCI Insight. 2017 Jul 20;2(14). doi: 10.1172/jci.insight.93652.

Abstract

Evaluation of T lymphocyte frequency provides prognostic information for patients with oral squamous cell cancer (OSCC). However, the effect of simultaneously evaluating T cell frequency and assessing suppressive elements and defects in antigen-processing machinery (APM) has not been clarified. Simultaneous characterization of CD3+, CD8+, FoxP3+, CD163+, and PD-L1+ cells using multispectral imaging was performed on sections from 119 patients with HPV- OSCC. Expression of β2-microglobulin, MHC class I heavy chain, and large multifunctional peptidase 10 was quantified, and all data were correlated with patient outcome. We found that, consistent with previous reports, high numbers of CD8+ T cells at the invasive margin correlated significantly with prolonged overall survival (OS), while the number of FoxP3+ or PD-L1+ cells did not. Compiling the number of FoxP3+ or PD-L1+ cells within 30 μm of CD8+ T cells identified a significant association with a high number of suppressive elements close to CD8+ T cells and reduced OS. Integrating this information into a cumulative suppression index (CSI) increased correlation with OS. Incorporating tumor expression levels of APM components with CSI further improved prognostic power. This multiparametric immune profiling may be useful for stratifying patients with OSCC for clinical trials.

摘要

评估T淋巴细胞频率可为口腔鳞状细胞癌(OSCC)患者提供预后信息。然而,同时评估T细胞频率以及评估抑制性元件和抗原加工机制(APM)缺陷的效果尚未明确。使用多光谱成像对119例HPV阴性OSCC患者的切片进行CD3 +、CD8 +、FoxP3 +、CD163 +和PD-L1 +细胞的同时表征。对β2-微球蛋白、MHC I类重链和大型多功能肽酶10的表达进行定量,所有数据均与患者预后相关。我们发现,与先前报道一致,侵袭边缘大量的CD8 + T细胞与延长的总生存期(OS)显著相关,而FoxP3 +或PD-L1 +细胞的数量则不然。汇总CD8 + T细胞30μm范围内FoxP3 +或PD-L1 +细胞的数量,发现与靠近CD8 + T细胞的大量抑制性元件和缩短的OS存在显著关联。将该信息整合到累积抑制指数(CSI)中可增加与OS的相关性。将APM成分的肿瘤表达水平与CSI相结合可进一步提高预后能力。这种多参数免疫谱分析可能有助于对OSCC患者进行分层以开展临床试验。

相似文献

1
Multiparametric immune profiling in HPV- oral squamous cell cancer.
JCI Insight. 2017 Jul 20;2(14). doi: 10.1172/jci.insight.93652.
2
Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell Carcinoma.
Cancers (Basel). 2021 Feb 4;13(4):620. doi: 10.3390/cancers13040620.
5
Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma.
Cancer Res Treat. 2016 Apr;48(2):527-36. doi: 10.4143/crt.2015.249. Epub 2015 Sep 15.
6
Prognostic value of tumor PD-L1 expression combined with CD8 tumor infiltrating lymphocytes in high grade serous ovarian cancer.
Int Immunopharmacol. 2017 Nov;52:7-14. doi: 10.1016/j.intimp.2017.08.017. Epub 2017 Aug 31.
8
Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma.
Oncotarget. 2017 Aug 3;8(39):66178-66194. doi: 10.18632/oncotarget.19842. eCollection 2017 Sep 12.
10
Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.
J Oral Pathol Med. 2008 Sep;37(8):485-9. doi: 10.1111/j.1600-0714.2008.00641.x. Epub 2008 Mar 18.

引用本文的文献

1
GARP-expressing Tregs as a source of immunosuppressive TGF-β1 in human tumors.
Cancer Immunol Immunother. 2025 Sep 13;74(10):308. doi: 10.1007/s00262-025-04157-2.
2
The regulatory role and mechanism of energy metabolism and immune response in head and neck cancer.
Genes Dis. 2025 Mar 19;12(6):101607. doi: 10.1016/j.gendis.2025.101607. eCollection 2025 Nov.
4
The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns.
NPJ Precis Oncol. 2025 Jul 1;9(1):217. doi: 10.1038/s41698-025-00983-w.
6
HIV status alters immune cell infiltration and activation profile in women with breast cancer.
Nat Commun. 2025 May 20;16(1):4699. doi: 10.1038/s41467-025-59408-8.
7
Assessment of immune infiltrate in oral cancer: An immunohistochemical study.
J Oral Maxillofac Pathol. 2025 Jan-Mar;29(1):66-75. doi: 10.4103/jomfp.jomfp_184_24. Epub 2025 Mar 28.
10

本文引用的文献

1
Immunoprofiling as a predictor of patient's response to cancer therapy-promises and challenges.
Curr Opin Immunol. 2017 Apr;45:60-72. doi: 10.1016/j.coi.2017.01.005. Epub 2017 Feb 20.
4
Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers.
Nature. 2016 Jun 16;534(7607):402-6. doi: 10.1038/nature18294. Epub 2016 May 23.
5
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.
Blood. 2016 Jun 16;127(24):3026-34. doi: 10.1182/blood-2015-12-686550. Epub 2016 Mar 30.
7
CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1.
Clin Cancer Res. 2016 Jul 15;22(14):3571-81. doi: 10.1158/1078-0432.CCR-15-2665. Epub 2016 Feb 10.
8
Novel technologies and emerging biomarkers for personalized cancer immunotherapy.
J Immunother Cancer. 2016 Jan 19;4:3. doi: 10.1186/s40425-016-0107-3. eCollection 2016.
9
High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma.
PLoS One. 2015 Nov 12;10(11):e0142656. doi: 10.1371/journal.pone.0142656. eCollection 2015.
10
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma.
J Immunother Cancer. 2015 Oct 20;3:47. doi: 10.1186/s40425-015-0091-z. eCollection 2015.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验